BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11723289)

  • 1. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy.
    Eurelings M; Ang CW; Notermans NC; Van Doorn PA; Jacobs BC; Van den Berg LH
    Neurology; 2001 Nov; 57(10):1909-12. PubMed ID: 11723289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
    Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b.
    Marfia GA; Pachatz C; Terracciano C; Leone G; Bernardini S; Bernardi G; Massa R
    Neurol Sci; 2005 Dec; 26(5):355-7. PubMed ID: 16388373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.
    Stork AC; Jacobs BC; Tio-Gillen AP; Eurelings M; Jansen MD; van den Berg LH; Notermans NC; van der Pol WL
    J Neuroimmunol; 2014 Mar; 268(1-2):89-94. PubMed ID: 24529728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
    Nobile-Orazio E; Manfredini E; Carpo M; Meucci N; Monaco S; Ferrari S; Bonetti B; Cavaletti G; Gemignani F; Durelli L
    Ann Neurol; 1994 Sep; 36(3):416-24. PubMed ID: 8080249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature.
    Stork AC; van der Pol WL; Franssen H; Jacobs BC; Notermans NC
    J Neurol; 2014 Jul; 261(7):1398-404. PubMed ID: 24781837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma.
    Ene CD; Tampa M; Nicolae I; Mitran CI; Mitran MI; Matei C; Caruntu A; Caruntu C; Georgescu SR
    J Immunol Res; 2020; 2020():2491265. PubMed ID: 32855975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy.
    Stork AC; Cats EA; Vlam L; Heezius E; Rooijakkers S; Herpers B; de Jong BA; Rijkers G; van Strijp J; Notermans NC; van den Berg LH; van der Pol WL
    J Neuroimmunol; 2016 Jan; 290():76-9. PubMed ID: 26711574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cytokine patterns in immunoglobulin m monoclonal gammopathy-associated polyneuropathy.
    Stork ACJ; Rijkers GT; Vlam L; Cats EA; de Jong BAW; Fritsch-Stork RDE; Veldink JH; van den Berg LH; Notermans NC; van der Pol WL
    Muscle Nerve; 2019 Jun; 59(6):694-698. PubMed ID: 30847948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune-mediated neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):956-8. PubMed ID: 20030259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
    Illa I; Rojas R; Gallardo E; Serrano C; Graus F
    Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
    Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
    J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings.
    Vrethem M; Reiser N; Lauermann C; Svanborg E
    Acta Neurol Scand; 2010 Jul; 122(1):52-7. PubMed ID: 20003083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases.
    Chassande B; Léger JM; Younes-Chennoufi AB; Bengoufa D; Maisonobe T; Bouche P; Baumann N
    Muscle Nerve; 1998 Jan; 21(1):55-62. PubMed ID: 9427224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
    Latov N
    Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.